UBS O'Connor’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-943,416
| Closed | -$881K | – | 374 |
|
|
2024
Q4 | $881K | Buy |
943,416
+315,126
| +50% | +$294K | 0.02% | 236 |
|
|
2024
Q3 | $741K | Buy |
628,290
+340,000
| +118% | +$401K | 0.02% | 303 |
|
|
2024
Q2 | $222K | Buy |
288,290
+28,790
| +11% | +$22.1K | 0.01% | 391 |
|
|
2024
Q1 | $791K | Buy |
259,500
+115,000
| +80% | +$351K | 0.02% | 295 |
|
|
2023
Q4 | $465K | Sell |
144,500
-5,500
| -4% | -$17.7K | 0.01% | 347 |
|
|
2023
Q3 | $576K | Buy |
150,000
+20,000
| +15% | +$76.8K | 0.01% | 376 |
|
|
2023
Q2 | $426K | Buy |
+130,000
| New | +$426K | 0.01% | 442 |
|